article graphic

News & insights

Filter by:

Filters

Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Germany as a location for pharmaceutical businesses - quo vadis, 2024?

Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany

11 January 2024
In-depth analysis

by Irina Rebin

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Employment, pensions & mobility

Work/Life: international employment news update

11 January 2024
Quick read

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises greentech on the realization and sale of the Agethorst solar park and on the conclusion of PPAs

10 January 2024

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Corporate/M&A & capital markets

Taylor Wessing advises Encavis Asset Management AG on the acquisition of two further wind farms in Brandenburg from UKA

10 January 2024

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Artificial intelligence

The interfaces between artificial intelligence and the Data Act

9 January 2024
Briefing

by Dr. Carolin Monsees, CIPP/E and Stephanie Richter, LL.M. (Torino), CIPP/E

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
China

The Top 10 Changes for Foreign Companies Under China’s New Company Law

8 January 2024
In-depth analysis

by Kai Kim (né Schlender), M.A.

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Data & cyber

GDPR compensation and culpability

27 December 2023
Briefing

by Alexander Schmalenberger, LL.B. and Dr. Benedikt Kohn, CIPP/E

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Patents & innovation

Higher Administrative Court of Münster: Subsequent authorization of a homeopathic medicinal product

19 December 2023
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Brands & advertising

CJEU on the interpretation of the term "advertising of medicinal products"

18 December 2023
Quick read

by Dr. Daniel Tietjen

Click here to find out more
Call To Action Arrow Image

Events

Hear from our experts as they discuss the latest legal issues.

Browse our events
Browse our events